- Home
- ARMN vs INNV Comparison
ARMN vs INNV Comparison
Compare ARMN & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARMN | INNV |
|---|---|---|
| Founded | 1992 | 2007 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Nursing Services |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 485.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | ARMN | INNV |
|---|---|---|
| Price | $15.85 | $5.79 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 1 | 1 |
| Target Price | ★ $17.00 | $5.00 |
| AVG Volume (30 Days) | ★ 1.7M | 189.4K |
| Earning Date | 10-29-2025 | 02-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.26 | N/A |
| Revenue | $770,175,000.00 | ★ $884,662,000.00 |
| Revenue This Year | $84.90 | $11.18 |
| Revenue Next Year | $69.90 | $9.58 |
| P/E Ratio | $65.19 | ★ N/A |
| Revenue Growth | ★ 58.96 | 12.48 |
| 52 Week Low | $3.29 | $2.60 |
| 52 Week High | $16.03 | $6.26 |
Technical Indicators
Market Signals| Indicator | ARMN | INNV |
|---|---|---|
| Relative Strength Index (RSI) | 78.24 | 61.30 |
| Support Level | $15.23 | $4.70 |
| Resistance Level | $15.95 | $6.15 |
| Average True Range (ATR) | 0.60 | 0.36 |
| MACD | 0.02 | 0.09 |
| Stochastic Oscillator | 84.91 | 89.66 |
Price Performance
Historical ComparisonAbout ARMN Aris Mining Corporation
Aris Mining Corp is engaged in the acquisition, exploration, development, and operation of gold properties in Colombia, Guyana, and Canada. It owns and operates its Segovia Operations, Soto Norte Project and Marmato Mine in Colombia, the Toroparu Project in Guyana, and the Juby Project in Ontario, Canada. The company generates revenue from the sale of gold and silver.
About INNV InnovAge Holding Corp.
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.